In the BioHarmony Drug Report Database

"Preview" Icon

Loteprednol etabonate

Alrex, Eysuvis, Inveltys, Lotemax, Lotemax Sm (loteprednol etabonate) is a small molecule pharmaceutical. Loteprednol etabonate was first approved as Alrex on 1998-03-09. It is used to treat allergic conjunctivitis, bacterial conjunctivitis, edema, inflammation, and iritis amongst others in the USA. Lotemax’s patents are valid until 2036-12-23 (FDA).

 

Trade Name

 

Alrex, Eysuvis, Inveltys, Lotemax, Lotemax Sm
 

Common Name

 

loteprednol etabonate
 

ChEMBL ID

 

CHEMBL1200865
 

Indication

 

allergic conjunctivitis, bacterial conjunctivitis, edema, inflammation, iritis, keratitis, rosacea, viral conjunctivitis
 

Drug Class

 

Prednisone and prednisolone derivatives

Image (chem structure or protein)

Loteprednol etabonate structure rendering